Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical trial.

Frontiers in clinical diabetes and healthcare Pub Date : 2023-10-18 eCollection Date: 2023-01-01 DOI:10.3389/fcdhc.2023.1247616
Arndís F Ólafsdóttir, Marcus Lind
{"title":"Evaluating a systematic intensive therapy using continuous glucose monitoring and intermittent scanning glucose monitoring in clinical diabetes care: a protocol for a multi-center randomized clinical trial.","authors":"Arndís F Ólafsdóttir,&nbsp;Marcus Lind","doi":"10.3389/fcdhc.2023.1247616","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>As many people with type 1 diabetes find it hard to reach the recommended glycemic goals, even with CGM, this study aims to determine if a closer, digitally supported collaboration on interpreting CGM data together with a diabetes nurse can improve glycemic control.</p><p><strong>Methods and analysis: </strong>A total of 120 individuals, 18 years and older and with HbA1c ≥ 58 mmol/mol will be included in the study at 8 different sites in Sweden and Norway. To be included, the participants must use a CGM or isCGM and be able to upload the data to the appropriate online service for their clinic and sensor. Both those with insulin pumps and insulin pens will be included in the study. Participants will be randomized into two different groups, that is, the intensive therapy group and the control group. The intensive therapy group will upload their glucose data weekly for the first 4 months and have telephone contact with their diabetes care team to receive support in interpreting CGM data and taking appropriate actions if their mean blood glucose level is above 8.4 mmol/L. After the 4-month-long intensive treatment phase, both randomized groups will have the same number of clinical visits and receive the same type of diabetes support.</p><p><strong>Discussion: </strong>It is of great importance to find new ways to help people with type 1 diabetes manage their condition as well as they can to help them achieve better glycemic control so that hopefully more people can achieve the recommended glycemic goals, which are associated with fewer diabetes complications. If it is shown that people with type 1 diabetes achieve better glycemic control with intensive therapy, then this can be incorporated into clinical praxis as an option for those not currently reaching the recommended glycemic goals.</p><p><strong>Clinical trial registration: </strong>https://clinicaltrials.gov/study/NCT03474393?locStr=Uddevalla,%20Sweden&country=Sweden&distance=50&cond=Diabetes&aggFilters=ages:adult%20older&state=V%C3%A4stra%20G%C3%B6taland%20County&city=Uddevalla&page=4&rank=34, identifier 03474393.</p>","PeriodicalId":73075,"journal":{"name":"Frontiers in clinical diabetes and healthcare","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619660/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in clinical diabetes and healthcare","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fcdhc.2023.1247616","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: As many people with type 1 diabetes find it hard to reach the recommended glycemic goals, even with CGM, this study aims to determine if a closer, digitally supported collaboration on interpreting CGM data together with a diabetes nurse can improve glycemic control.

Methods and analysis: A total of 120 individuals, 18 years and older and with HbA1c ≥ 58 mmol/mol will be included in the study at 8 different sites in Sweden and Norway. To be included, the participants must use a CGM or isCGM and be able to upload the data to the appropriate online service for their clinic and sensor. Both those with insulin pumps and insulin pens will be included in the study. Participants will be randomized into two different groups, that is, the intensive therapy group and the control group. The intensive therapy group will upload their glucose data weekly for the first 4 months and have telephone contact with their diabetes care team to receive support in interpreting CGM data and taking appropriate actions if their mean blood glucose level is above 8.4 mmol/L. After the 4-month-long intensive treatment phase, both randomized groups will have the same number of clinical visits and receive the same type of diabetes support.

Discussion: It is of great importance to find new ways to help people with type 1 diabetes manage their condition as well as they can to help them achieve better glycemic control so that hopefully more people can achieve the recommended glycemic goals, which are associated with fewer diabetes complications. If it is shown that people with type 1 diabetes achieve better glycemic control with intensive therapy, then this can be incorporated into clinical praxis as an option for those not currently reaching the recommended glycemic goals.

Clinical trial registration: https://clinicaltrials.gov/study/NCT03474393?locStr=Uddevalla,%20Sweden&country=Sweden&distance=50&cond=Diabetes&aggFilters=ages:adult%20older&state=V%C3%A4stra%20G%C3%B6taland%20County&city=Uddevalla&page=4&rank=34, identifier 03474393.

Abstract Image

在临床糖尿病护理中使用连续血糖监测和间歇性扫描血糖监测评估系统强化治疗:一项多中心随机临床试验的方案。
引言:由于许多1型糖尿病患者发现,即使使用CGM,也很难达到推荐的血糖目标,本研究旨在确定与糖尿病护士在解释CGM数据方面进行更密切的数字支持合作是否可以改善血糖控制。方法和分析:在瑞典和挪威的8个不同地点,共有120名18岁及以上、HbA1c≥58 mmol/mol的个体将被纳入研究。参与者必须使用CGM或isCGM,并能够将数据上传到其诊所和传感器的适当在线服务。这项研究将包括那些使用胰岛素泵和胰岛素笔的人。参与者将被随机分为两组,即强化治疗组和对照组。强化治疗组将在前4个月每周上传他们的血糖数据,并与他们的糖尿病护理团队进行电话联系,以获得解释CGM数据的支持,并在他们的平均血糖水平高于8.4 mmol/L时采取适当行动。在为期4个月的强化治疗阶段后,两个随机组的临床访视次数相同,并接受相同类型的糖尿病支持。讨论:找到新的方法来帮助1型糖尿病患者控制病情,帮助他们实现更好的血糖控制,这一点非常重要,希望更多的人能够实现推荐的血糖目标,从而减少糖尿病并发症。如果有证据表明,1型糖尿病患者通过强化治疗实现了更好的血糖控制,那么这可以作为目前尚未达到推荐血糖目标的患者的一种选择纳入临床实践。临床试验注册:https://clinicaltrials.gov/study/NCT03474393?locStr=Uddevalla,%20瑞典和国家=瑞典和距离=50&cond=糖尿病和aggFilters=年龄:成年人%20老年人和州=V%C3%A4stra%20G%C3%B6taland%20县和市=乌德瓦拉和页面=4&rank=34,标识符03474393。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信